Global Closed System Transfer Devices (CSTD) Market Size (2024 - 2029)

The closed system transfer devices market is poised for significant growth, driven by factors such as the increasing prevalence of cancer and the rise in oncology product approvals. The market's expansion is further supported by advancements in technology and heightened awareness of the safety benefits these devices offer in reducing exposure to hazardous drugs. Despite the positive outlook, challenges such as high implementation costs and inconsistent regulatory guidelines in some regions may impede market growth.

Market Size of Global Closed System Transfer Devices (CSTD) Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Closed System Transfer Devices (CSTD) Market
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 18.00 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Closed System Transfer Devices (CSTD) Market Analysis

The closed system transfer devices are expected to project a CAGR of 18% over the forecast period (2022-2027).

The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. However, with the advent of the COVID-19 infection, large-scale vaccinations were performed all over the world, which majorly benefitted the closed system transfer devices market. An article titled 'A Needle-Free Jet Injection System for Controlled Release and Repeated Biopharmaceutical Delivery' published in the journal of Pharmaceuticals in November 2021 studied the successful design and working model of an air-driven needle-free jet injector, which is a type of needleless closed system transfer device, for use during the large-scale COVID-19 vaccinations. The model had a drug delivery efficiency of 96.7% for 0.2 mL/shot injections and 97.8% drug transfer efficiency at 0.5 mL/shot. The proposed model could be used commercially, as the WHO guidelines for injection devices require 86% or higher accuracy. Such developments in closed system transfer devices are likely to add to the growth of the market over the forecast period.

The increasing prevalence of cancer around the world and the rise in the number of oncology product approvals are major factors attributing to the growth of the studied market. According to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounts for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. The huge number of people affected by cancer, creating a demand for innovative drug delivery technologies is expected to add to the growth of the closed system transfer devices market.

Limiting the exposure to hazardous drugs/chemicals is important due to the potential harm that might cause to healthcare workers and patients in healthcare/clinical setups. Due to the increased incidence of hazardous drug exposures in many countries, the regulatory authorities have taken many initiatives to ensure the safety of patients and healthcare workers. Owing to the factors such as growing awareness regarding usage of closed system transfer devices and increased oncology drug approvals global closed system transfer devices (CSTD) market is expected to grow significantly. Furthermore, the technological advancements in closed system transfer devices anticipated to boost the market growth.

However, the high cost involved in the implementation of closed system transfer devices directly increases the cost of treatment/products. Furthermore, improper regulatory guidelines in developing and underdeveloped countries may hamper market growth over the forecast period.

Closed System Transfer Devices (CSTD) Industry Segmentation

Closed system transfer devices (CSTD) are drug transfer devices that used to restrict the exposure of hazardous and harmful drugs or vapours to the outer environment. These devices ensure patient/healthcare workers safety during the usage of hazardous drugs/chemicals. The Closed System Transfer Devices (CSTD) Market is Segmented by Type (Needless Systems, Membrane to Membrane Systems), By Closing Mechanism (Colour to Colour Alignment Systems, Lueker Lock Systems, Push to Turn systems, and Click to Lock Systems), By Component (Syringe Safety Devices, Vial Access Devices, Bag Access Devices, and Others), By End-Use (Hospitals, Oncology Clinics and Oncology Centers, and Others) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD million) for the above segments. 

By Type
Needless Systems
Membrane to Membrane Systems
By Closing Mechanism
Colour to Colour Alignment Systems
Lueker Lock Systems
Push to Turn systems
Click to Lock Systems
By Component
Syringe Safety Devices
Vial Access Devices
Bag Access Devices
Others
By Technology
Compartmentalize Devices
Diaphragm Based Devices
Air Filtration Devices
By End-Use
Hospitals
Oncology Clinics and Oncology Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Closed System Transfer Devices (CSTD) Market Size Summary

The closed system transfer devices market is poised for significant growth, driven by the increasing prevalence of chronic diseases such as cancer and diabetes, and the rising demand for innovative drug delivery technologies. The market is benefiting from advancements in needleless systems, which offer advantages like ease of use and reduced contamination risk. The COVID-19 pandemic has also played a pivotal role in accelerating market growth, as large-scale vaccination efforts highlighted the efficiency and safety of closed system transfer devices. Regulatory initiatives and increased oncology drug approvals further bolster market expansion, particularly in regions like North America and Asia Pacific, where there is a growing focus on patient safety and cancer research.

Despite the promising growth trajectory, the market faces challenges such as high implementation costs and inconsistent regulatory guidelines in developing regions. However, the ongoing technological advancements and growing awareness of the benefits of closed system transfer devices are expected to drive market growth. Key players in the market are actively engaging in product innovations and geographical expansion to strengthen their market presence. The competitive landscape remains moderately consolidated, with major companies like Becton, Dickinson and Company, ICU Medical, Inc., and Baxter International Inc. leading the charge in developing and launching new products to meet the evolving needs of the healthcare industry.

Explore More

Global Closed System Transfer Devices (CSTD) Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Cancer and increasing Oncology Drug Approvals

      2. 1.2.2 Advancements in Technologies and Improving Regulatory Guidelines

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost for Closed System Transfer Device Implementation

      2. 1.3.2 Lack of Proper Regulatory Guidelines In Many of the Countries

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

    1. 2.1 By Type

      1. 2.1.1 Needless Systems

      2. 2.1.2 Membrane to Membrane Systems

    2. 2.2 By Closing Mechanism

      1. 2.2.1 Colour to Colour Alignment Systems

      2. 2.2.2 Lueker Lock Systems

      3. 2.2.3 Push to Turn systems

      4. 2.2.4 Click to Lock Systems

    3. 2.3 By Component

      1. 2.3.1 Syringe Safety Devices

      2. 2.3.2 Vial Access Devices

      3. 2.3.3 Bag Access Devices

      4. 2.3.4 Others

    4. 2.4 By Technology

      1. 2.4.1 Compartmentalize Devices

      2. 2.4.2 Diaphragm Based Devices

      3. 2.4.3 Air Filtration Devices

    5. 2.5 By End-Use

      1. 2.5.1 Hospitals

      2. 2.5.2 Oncology Clinics and Oncology Centers

      3. 2.5.3 Others

    6. 2.6 Geography

      1. 2.6.1 North America

        1. 2.6.1.1 United States

        2. 2.6.1.2 Canada

        3. 2.6.1.3 Mexico

      2. 2.6.2 Europe

        1. 2.6.2.1 Germany

        2. 2.6.2.2 United Kingdom

        3. 2.6.2.3 France

        4. 2.6.2.4 Italy

        5. 2.6.2.5 Spain

        6. 2.6.2.6 Rest of Europe

      3. 2.6.3 Asia-Pacific

        1. 2.6.3.1 China

        2. 2.6.3.2 Japan

        3. 2.6.3.3 India

        4. 2.6.3.4 Australia

        5. 2.6.3.5 South Korea

        6. 2.6.3.6 Rest of Asia-Pacific

      4. 2.6.4 Middle-East and Africa

        1. 2.6.4.1 GCC

        2. 2.6.4.2 South Africa

        3. 2.6.4.3 Rest of Middle-East and Africa

      5. 2.6.5 South America

        1. 2.6.5.1 Brazil

        2. 2.6.5.2 Argentina

        3. 2.6.5.3 Rest of South America

Global Closed System Transfer Devices (CSTD) Market Size FAQs

The Global Closed System Transfer Devices (CSTD) Market is projected to register a CAGR of 18% during the forecast period (2024-2029)

Becton, Dickinson and Company, ICU Medical, Inc., Caragen Ltd., Baxter International Inc. and B. Braun Melsungen AG are the major companies operating in the Global Closed System Transfer Devices (CSTD) Market.

Closed System Transfer Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)